Impact News +++ Why Opendoor Technologies Stock Popped Today (Fool) +++ OPENDOOR Aktie -3,33%

Gewinn & Umsatz News zur BIOMARIN Aktie

>BIOMARIN Aktienkurs

48.29 EUR -1.1% (Tradegate)

Ask: 50.3 EUR / 109 Stück

Bid: 50.08 EUR / 109 Stück

Tagesumsatz: 1 Stück

Realtime Kurs von 8 bis 22 Uhr!

BIOMARIN Aktie über LYNX handeln

Intraday

1 Jahr

>BIOMARIN Performance

1 Woche: -4,7%

1 Monat: +0,2%

3 Monate: -8,0%

6 Monate: -18,8%

1 Jahr: -38,1%

laufendes Jahr: -23,8%

>BIOMARIN Aktie

Name:

BIOMARIN PHAR. DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US09061G1013 / 924801

Symbol/ Ticker:

BM8 (Frankfurt) / BMRN (NASDAQ)

Kürzel:

FRA:BM8, ETR:BM8, BM8:GR, NASDAQ:BMRN

Index:

Webseite:

https://www.biomarin.com/

Marktkapitalisierung:

9580 Mio. EUR

Umsatz:

2548.11 Mio. EUR

EBITDA:

696.73 Mio. EUR

Gewinn je Aktie:

2.038 EUR

Schulden:

519.95 Mio. EUR

Liquide Mittel:

1096.98 Mio. EUR

Umsatz-/ Gewinnwachstum:

14.8% / 109.4%

KGV/ KGV lG:

21.36 / 13.64

KUV/ KBV/ PEG:

3.83 / 1.91 / 0.83

Gewinnm./ Eigenkapitalr.:

17.76% / 9.64%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

BIOMARIN

Letzte Datenerhebung:

16.07.25

>BIOMARIN Eigentümer

Aktien: 191.78 Mio. St.

f.h. Aktien: 179.36 Mio. St.

Insider Eigner: 0.85%

Instit. Eigner: 99.01%

Leerverk. Aktien: 3.42%

>BIOMARIN Peer Group

ANI PHARMA

APELLIS

CHARLES RIVER

EDWARDS LIFESCIENCES

EXACT SCIENCES

INCYTE

IONIS

LANTHEUS

UNIVERSAL HEALTH SERVICES

ZOETIS

>BIOMARIN Chart & Kurs - NASDAQ

>BIOMARIN Gewinn & Umsatz News

01.05.25 - 22:36	Biomarin Pharmaceutical Inc. Q1 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) released earnings for its first quarter that increased from last year and beat the Street estimates.The company's bottom line came in at ......

24.02.25 - 16:09	Oppenheimer upgrades BioMarin on long term outlook (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

19.02.25 - 23:01	BioMarin Pharma Expects Double-Digit Revenue And Profitability Growth In 2025 (AFX)
	WASHINGTON (dpa-AFX) - While reporting its fourth-quarter results on Wednesday, BioMarin Pharmaceutical Inc. (BMRN) issued financial guidance for the full year 2025.The company expects revenues of......

19.02.25 - 22:36	Biomarin Pharmaceutical Inc. Q4 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) announced a profit for its fourth quarter that increased from the same period last year and beat the Street estimates.The company's earni......

29.10.24 - 21:37	Biomarin Pharmaceutical Inc. Q3 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) revealed earnings for its third quarter that increased from the same period last year and beat the Street estimates.The company's earning......

24.09.24 - 15:02	Biomarin Pharmaceutical Inc Reaffirming Its Long-Term Financial Guidance And Outlook That It Presented During Investor Day (Reuters EN)
	Biomarin Pharmaceutical Inc Reaffirming Its Long-Term Financial Guidance And Outlook That It Presented During Investor Day...

05.08.24 - 23:15	Biomarin Pharmaceutical Inc reports results for the quarter ended in June - Earnings Summary (Reuters EN)
	Biomarin Pharmaceutical Inc reports results for the quarter ended in June - Earnings Summary...

05.08.24 - 22:44	BioMarin climbs after Q2 results beat (Reuters EN)
	BioMarin climbs after Q2 results beat...

05.08.24 - 22:30	Biomarin Pharmaceutical Inc. Q2 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) announced earnings for its second quarter that increased from the same period last year and beat the Street estimates.The company's earni......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Malern und Dichtern war es stets gleichermaßen erlaubt zu sagen, was auch immer ihnen beliebt. - Quintus Flaccus Horaz

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram